Efficacy and safety of olaparib, olaparib plus bevacizumab and niraparib maintenance treatment in Japanese patients with platinum-sensitive advanced ovarian cancer.
Nakamura K, Matsuoka H, Yorimitsu M, Ogawa M, Kanemori M, Sueoka K, Kozai A, Nakamura H, Haruma T, Shiroyama Y, Hayata Y, Sugii H, Ueda A, Kurihara S, Urayama S, Shimizu M, Masuyama H.
Nakamura K, et al. Among authors: matsuoka h.
Jpn J Clin Oncol. 2024 Jan 7;54(1):31-37. doi: 10.1093/jjco/hyad125.
Jpn J Clin Oncol. 2024.
PMID: 37721176
Free PMC article.